vs
PAR PACIFIC HOLDINGS, INC.（PARR）とSolventum（SOLV）の財務データ比較。上の社名をクリックして会社を切り替えられます
Solventumの直近四半期売上が大きい（$2.0B vs $1.8B、PAR PACIFIC HOLDINGS, INC.の約1.1倍）。PAR PACIFIC HOLDINGS, INC.の純利益率が高く（4.3% vs 3.2%、差は1.1%）。PAR PACIFIC HOLDINGS, INC.の前年同期比売上増加率が高い（-1.0% vs -3.7%）。PAR PACIFIC HOLDINGS, INC.の直近四半期フリーキャッシュフローが多い（$66.3M vs $32.0M）。過去8四半期でSolventumの売上複合成長率が高い（-0.4% vs -4.3%）
Par Pacific Holdingsは米国ヒューストンに本拠を置く石油・ガスの探査・生産企業である。破産再建後はPar Petroleum Corporationの名称で事業を展開し、2015年10月20日に現社名に変更、2017年にはフォーチュン1000に選出された。
Solventum Corporationはアメリカ発祥のヘルスケア企業で、2024年4月1日に多岐にわたる事業を展開する世界的大手企業3Mからスピンオフして独立しました。旧3M医療部門の技術や事業資産を承継し、世界各国の顧客に医療関連の製品・サービスを提供しています。
PARR vs SOLV — 直接比較
損益計算書 — Q4 FY2025 vs Q4 FY2025
| 指標 | | |
|---|---|---|
| 売上 | $1.8B | $2.0B |
| 純利益 | $77.7M | $63.0M |
| 粗利率 | — | 51.4% |
| 営業利益率 | 5.5% | 6.3% |
| 純利益率 | 4.3% | 3.2% |
| 売上前年比 | -1.0% | -3.7% |
| 純利益前年比 | 239.5% | 103.2% |
| EPS（希薄化後） | $1.40 | $0.37 |
緑 = その指標でリード。会計年度がずれている場合は期間が異なる場合あり
8四半期 売上・利益トレンド
並べて比較する四半期履歴。決算期がずれていても暦四半期で整列
| Q4 25 | $1.8B | $2.0B | ||
| Q3 25 | $2.0B | $2.1B | ||
| Q2 25 | $1.9B | $2.2B | ||
| Q1 25 | $1.7B | $2.1B | ||
| Q4 24 | $1.8B | $2.1B | ||
| Q3 24 | $2.1B | $2.1B | ||
| Q2 24 | $2.0B | $2.1B | ||
| Q1 24 | $2.0B | $2.0B |
| Q4 25 | $77.7M | $63.0M | ||
| Q3 25 | $262.6M | $1.3B | ||
| Q2 25 | $59.5M | $90.0M | ||
| Q1 25 | $-30.4M | $137.0M | ||
| Q4 24 | $-55.7M | $31.0M | ||
| Q3 24 | $7.5M | $122.0M | ||
| Q2 24 | $18.6M | $89.0M | ||
| Q1 24 | $-3.8M | $237.0M |
| Q4 25 | — | 51.4% | ||
| Q3 25 | — | 54.2% | ||
| Q2 25 | — | 54.4% | ||
| Q1 25 | — | 53.8% | ||
| Q4 24 | — | 53.9% | ||
| Q3 24 | — | 56.0% | ||
| Q2 24 | — | 54.6% | ||
| Q1 24 | — | 58.1% |
| Q4 25 | 5.5% | 6.3% | ||
| Q3 25 | 17.8% | 80.6% | ||
| Q2 25 | 5.1% | 9.9% | ||
| Q1 25 | -0.9% | 7.3% | ||
| Q4 24 | -2.6% | 6.6% | ||
| Q3 24 | 1.7% | 13.2% | ||
| Q2 24 | 2.4% | 11.7% | ||
| Q1 24 | 0.5% | 18.9% |
| Q4 25 | 4.3% | 3.2% | ||
| Q3 25 | 13.0% | 60.4% | ||
| Q2 25 | 3.1% | 4.2% | ||
| Q1 25 | -1.7% | 6.6% | ||
| Q4 24 | -3.0% | 1.5% | ||
| Q3 24 | 0.3% | 5.9% | ||
| Q2 24 | 0.9% | 4.3% | ||
| Q1 24 | -0.2% | 11.8% |
| Q4 25 | $1.40 | $0.37 | ||
| Q3 25 | $5.16 | $7.22 | ||
| Q2 25 | $1.17 | $0.51 | ||
| Q1 25 | $-0.57 | $0.78 | ||
| Q4 24 | $-0.98 | $0.18 | ||
| Q3 24 | $0.13 | $0.70 | ||
| Q2 24 | $0.32 | $0.51 | ||
| Q1 24 | $-0.06 | $1.37 |
貸借対照表と財務力
直近四半期の流動性・レバレッジ・純資産のスナップショット
| 指標 | | |
|---|---|---|
| 現金・短期投資手元流動性 | $164.1M | $878.0M |
| 総負債低いほど良い | $802.9M | $5.0B |
| 株主資本純資産 | $1.5B | $5.0B |
| 総資産 | $3.8B | $14.3B |
| 負債/資本比率低いほどレバレッジが低い | 0.53× | 1.00× |
8四半期トレンド — 暦四半期で整列
| Q4 25 | $164.1M | $878.0M | ||
| Q3 25 | $159.1M | $1.6B | ||
| Q2 25 | $169.2M | $492.0M | ||
| Q1 25 | $133.7M | $534.0M | ||
| Q4 24 | $191.9M | $762.0M | ||
| Q3 24 | $183.0M | $772.0M | ||
| Q2 24 | $179.7M | $897.0M | ||
| Q1 24 | $228.3M | $996.0M |
| Q4 25 | $802.9M | $5.0B | ||
| Q3 25 | $967.1M | $5.1B | ||
| Q2 25 | $1.1B | $7.8B | ||
| Q1 25 | $1.2B | $7.9B | ||
| Q4 24 | $1.1B | $8.0B | ||
| Q3 24 | $1.0B | $8.1B | ||
| Q2 24 | $1.1B | $8.3B | ||
| Q1 24 | $639.5M | $8.3B |
| Q4 25 | $1.5B | $5.0B | ||
| Q3 25 | $1.4B | $5.0B | ||
| Q2 25 | $1.1B | $3.6B | ||
| Q1 25 | $1.1B | $3.3B | ||
| Q4 24 | $1.2B | $3.0B | ||
| Q3 24 | $1.3B | $3.2B | ||
| Q2 24 | $1.3B | $2.9B | ||
| Q1 24 | $1.3B | $3.9B |
| Q4 25 | $3.8B | $14.3B | ||
| Q3 25 | $4.1B | $14.0B | ||
| Q2 25 | $3.9B | $15.1B | ||
| Q1 25 | $3.8B | $14.5B | ||
| Q4 24 | $3.8B | $14.5B | ||
| Q3 24 | $3.9B | $14.7B | ||
| Q2 24 | $3.9B | $14.6B | ||
| Q1 24 | $3.8B | $14.7B |
| Q4 25 | 0.53× | 1.00× | ||
| Q3 25 | 0.69× | 1.03× | ||
| Q2 25 | 0.97× | 2.14× | ||
| Q1 25 | 1.04× | 2.43× | ||
| Q4 24 | 0.93× | 2.71× | ||
| Q3 24 | 0.83× | 2.54× | ||
| Q2 24 | 0.84× | 2.90× | ||
| Q1 24 | 0.49× | 2.16× |
キャッシュフローと資本効率
再投資後に実際に生み出すキャッシュ。純利益より操作が難しい
| 指標 | | |
|---|---|---|
| 営業キャッシュフロー直近四半期 | $93.8M | $95.0M |
| フリーキャッシュフロー営業CF - 設備投資 | $66.3M | $32.0M |
| FCFマージンFCF / 売上 | 3.7% | 1.6% |
| 設備投資強度設備投資 / 売上 | 1.5% | 3.2% |
| キャッシュ転換率営業CF / 純利益 | 1.21× | 1.51× |
| 直近12ヶ月FCF直近4四半期 | $296.5M | $-10.0M |
8四半期トレンド — 暦四半期で整列
| Q4 25 | $93.8M | $95.0M | ||
| Q3 25 | $219.4M | $76.0M | ||
| Q2 25 | $133.6M | $169.0M | ||
| Q1 25 | $-1.4M | $29.0M | ||
| Q4 24 | $-15.5M | $219.0M | ||
| Q3 24 | $78.5M | $169.0M | ||
| Q2 24 | $-4.7M | $355.0M | ||
| Q1 24 | $25.4M | $442.0M |
| Q4 25 | $66.3M | $32.0M | ||
| Q3 25 | $187.1M | $-21.0M | ||
| Q2 25 | $85.5M | $59.0M | ||
| Q1 25 | $-42.3M | $-80.0M | ||
| Q4 24 | $-63.1M | $92.0M | ||
| Q3 24 | $50.2M | $76.0M | ||
| Q2 24 | $-41.6M | $297.0M | ||
| Q1 24 | $2.8M | $340.0M |
| Q4 25 | 3.7% | 1.6% | ||
| Q3 25 | 9.3% | -1.0% | ||
| Q2 25 | 4.5% | 2.7% | ||
| Q1 25 | -2.4% | -3.9% | ||
| Q4 24 | -3.4% | 4.4% | ||
| Q3 24 | 2.3% | 3.7% | ||
| Q2 24 | -2.1% | 14.3% | ||
| Q1 24 | 0.1% | 16.9% |
| Q4 25 | 1.5% | 3.2% | ||
| Q3 25 | 1.6% | 4.6% | ||
| Q2 25 | 2.5% | 5.1% | ||
| Q1 25 | 2.3% | 5.3% | ||
| Q4 24 | 2.6% | 6.1% | ||
| Q3 24 | 1.3% | 4.5% | ||
| Q2 24 | 1.8% | 2.8% | ||
| Q1 24 | 1.1% | 5.1% |
| Q4 25 | 1.21× | 1.51× | ||
| Q3 25 | 0.84× | 0.06× | ||
| Q2 25 | 2.25× | 1.88× | ||
| Q1 25 | — | 0.21× | ||
| Q4 24 | — | 7.06× | ||
| Q3 24 | 10.48× | 1.39× | ||
| Q2 24 | -0.25× | 3.99× | ||
| Q1 24 | — | 1.86× |
財務フロー比較
売上 → 粗利 → 営業利益 → 純利益のサンキー図
セグメント別売上内訳
PARR
| Distillates | $750.6M | 41% |
| Gasoline | $603.9M | 33% |
| Other Refined Products | $348.8M | 19% |
| Logistics | $73.7M | 4% |
| Other Revenues | $44.8M | 2% |
SOLV
| Infection Prevention And Surgical Solutions | $752.0M | 38% |
| Cost Of Software And Rentals | $508.0M | 25% |
| Health Information Systems Segment | $347.0M | 17% |
| Dental Solutions Segment | $343.0M | 17% |
| Related Party | $14.0M | 1% |
